ASSOCIATION OF VITAMIN D LEVEL AND SEVERITY OF COVID-19 DISEASE
Amol Singhsakul, Bancha Satirapoj, Sirinthip Nimitphuwadon, Sirate Rapeepattana, Saovanee Benjamanukul, Sasiwimon Traiyan
Journal of Southeast Asian Medical Research, doi:10.55374/jseamed.v8.202
Background: Studies indicate that vitamin D can lower the incidence of viral respiratory infections and is necessary for the human immune system to function properly. Vitamin D deficiency may be a risk factor for the severity of COVID-19, including mortality, hospitalization, and length of hospital stay. Objectives: This study aimed to investigate the association between vitamin D levels and the severity of COVID-19 disease. Methods: The participants were COVID-19 patients aged 18 years or older who tested positive for the virus on Real-Time PCR tests, treated as inpatients at Banphaeo General Hospital between September 1 and November 30, 2021. For each patient, baseline characteristics, including sex, weight, height, and underlying diseases, were collected. Three categories were used to categorize COVID-19 disease: mild, moderate, and severe. At the beginning of the study, blood tests were performed on each patient to determine their 25-hydroxyvitamin D levels. Results: Of 97 patients, 64 were male (66%), with a mean age of 50.8±17.7 years. The mean vitamin D level was 27.8±9.6 ng/mL, with 45 (46.4%) showing vitamin D deficiency and 39 (40.2%) indicating vitamin D insufficiency. Among COVID-19 patients with vitamin D deficiency, 28 (63.6%) were classified as severe, compared to only 16 severe cases (36.4%) among those without vitamin D deficiency, demonstrating statistically significant differences (p=0.006). Patients with vitamin D deficiency had a 3.97 times higher risk of experiencing severity (95% CI: 1.67, 9.41, p=0.002) than those without a vitamin D deficit. After adjusting for variable factors, results indicated that patients with vitamin D deficiency had a 3.78-fold increased risk of getting severe illness than those without deficiency (95% CI: 1.28, 11.19, p=0.016). Conclusion: These findings suggested that vitamin D deficiency was associated with the severity of COVID-19.
Conflict of interest The authors declare they have no conflict of interest.
References
Adami, Rossini, Bogliolo, Cantatore, Varenna et al., An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis, Mod Rheumatol
Annweiler, Hanotte, De L'eprevier, Sabatier, Lafaie et al., Vitamin D and survival in COVID-19 patients: A quasi-experimental study, J Steroid Biochem Mol Biol
Aranow, Journal of investigative medicine : the official publication of the, American Federation for Clinical Research
Campi, Gennari, Merlotti, Mingiano, Frosali et al., Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy, BMC Infect Dis
Chailurkit, Aekplakorn, Ongphiphadhanakul, Regional variation and determinants of vitamin D status in sunshine-abundant Thailand, BMC Public Health
D'avolio, Avataneo, Manca, Cusato, Nicolò et al., 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients
Dimitrov, White, Species-specific regulation of innate immunity by vitamin D signaling, J Steroid Biochem Mol Biol
Hanff, Harhay, Brown, Cohen, Mohareb, Is there an association between COVID-19 mortality and the renin-angiotensin system? A call for epidemiologic investigations, Clin Infect Dis
Hansdottir, Monick, Hinde, Lovan, Look et al., Respiratory epithelial cells convert inactive vitamin D to its active form: Potential effects on host defense, J Immunol
Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley et al., Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline, J Clin Endocrinol Metab
Hossein-Nezhad, Holick, Vitamin D for health: A global perspective, Mayo Clin Proc
Jiang, Chou, Chen, Cathelicidin attenuates hyperoxia-induced lung injury by inhibiting oxidative stress in newborn rats, Free Radic Biol Med
Karatekin, Kaya, Salihoğlu, Balci, Nuhoğlu, Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers, Eur J Clin Nutr
Martineau, Jolliffe, Greenberg, Aloia, Bergman et al., Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis, Health Technol Assess
Mercola, Grant, Wagner, Evidence regarding vitamin D and risk of COVID-19 and its severity, Nutrients
Murai, Fernandes, Sales, Pinto, Goessler et al., Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: A randomized clinical trial, JAMA
Nimitphong, Holick, Vitamin D status and sun exposure in southeast Asia, Dermatoendocrinol
Palacios, Gonzalez, Is vitamin D deficiency a major global public health problem?, J Steroid Biochem Mol Biol
Rhodes, Subramanian, Laird, Griffin, Kenny, Perspective: Vitamin D deficiency and COVID-19 severity -plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis, J Intern Med
Sassi, Tamone, Amelio, Vitamin D: Nutrient, hormone, and immunomodulator, Nutrients
Shah, Varna, Sharma, Mavalankar, Does vitamin D supplementation reduce COVID-19 severity?: a systematic review, QJM
Siwamogsatham, Ongphiphadhanakul, Tangpricha, Vitamin D deficiency in Thailand, J Clin Transl Endocrinol
Teshome, Adane, Girma, Mekonnen, The impact of vitamin D level on COVID-19 infection: Systematic review and meta-analysis, Front Public Health
Wang, Joshi, Jackson, Christensen, Nayfeh, Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and metaanalysis, Clin Endocrinol (Oxf)
Wiersinga, Rhodes, Cheng, Peacock, Prescott, Pathophysiology, transmission, diagnosis, and treatment of Coronavirus disease 2019 (COVID-19): A review, JAMA
Wolff, Nee, Hickey, Marschollek, Risk factors for Covid-19 severity and fatality: a structured literature review, Infection
Ye, Tang, Liao, Shaw, Deng et al., Does serum vitamin D level affect COVID-19 infection and its severity? -A case-control study, J Am Coll Nutr
{ 'indexed': {'date-parts': [[2024, 6, 9]], 'date-time': '2024-06-09T03:10:45Z', 'timestamp': 1717902645165},
'reference-count': 29,
'publisher': 'Phramongkutklao Hospital Foundation',
'license': [ { 'start': { 'date-parts': [[2024, 6, 9]],
'date-time': '2024-06-09T00:00:00Z',
'timestamp': 1717891200000},
'content-version': 'unspecified',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>Background: Studies indicate that vitamin D can lower the incidence of viral '
'respiratory infections and is necessary for the human immune system to function properly. '
'Vitamin D deficiency may be a risk factor for the severity of COVID-19, including mortality, '
'hospitalization, and length of hospital stay.\n'
'Objectives: This study aimed to investigate the association between vitamin D levels and the '
'severity of COVID-19 disease.\n'
'Methods: The participants were COVID-19 patients aged 18 years or older who tested positive '
'for the virus on Real-Time PCR tests, treated as inpatients at Banphaeo General Hospital '
'between September 1 and November 30, 2021. For each patient, baseline characteristics, '
'including sex, weight, height, and underlying diseases, were collected. Three categories were '
'used to categorize COVID-19 disease: mild, moderate, and severe. At the beginning of the '
'study, blood tests were performed on each patient to determine their 25-hydroxyvitamin D '
'levels.\n'
'Results: Of 97 patients, 64 were male (66%), with a mean age of 50.8±17.7 years. The mean '
'vitamin D level was 27.8±9.6 ng/mL, with 45 (46.4%) showing vitamin D deficiency and 39 '
'(40.2%) indicating vitamin D insufficiency. Among COVID-19 patients with vitamin D '
'deficiency, 28 (63.6%) were classified as severe, compared to only 16 severe cases (36.4%) '
'among those without vitamin D deficiency, demonstrating statistically significant differences '
'(p=0.006). Patients with vitamin D deficiency had a 3.97 times higher risk of experiencing '
'severity (95% CI: 1.67, 9.41, p=0.002) than those without a vitamin D deficit. After '
'adjusting for variable factors, results indicated that patients with vitamin D deficiency had '
'a 3.78-fold increased risk of getting severe illness than those without deficiency (95% CI: '
'1.28, 11.19, p=0.016). Conclusion: These findings suggested that vitamin D deficiency was '
'associated with the severity of COVID-19.</jats:p>',
'DOI': '10.55374/jseamed.v8.202',
'type': 'journal-article',
'created': {'date-parts': [[2024, 6, 9]], 'date-time': '2024-06-09T02:57:09Z', 'timestamp': 1717901829000},
'page': 'e0202',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'ASSOCIATION OF VITAMIN D LEVEL AND SEVERITY OF COVID-19 DISEASE',
'prefix': '10.55374',
'volume': '8',
'author': [ {'given': 'Amol', 'family': 'Singhsakul', 'sequence': 'first', 'affiliation': []},
{'given': 'Bancha', 'family': 'Satirapoj', 'sequence': 'additional', 'affiliation': []},
{'given': 'Sirinthip', 'family': 'Nimitphuwadon', 'sequence': 'additional', 'affiliation': []},
{'given': 'Sirate', 'family': 'Rapeepattana', 'sequence': 'additional', 'affiliation': []},
{'given': 'Saovanee', 'family': 'Benjamanukul', 'sequence': 'additional', 'affiliation': []},
{'given': 'Sasiwimon', 'family': 'Traiyan', 'sequence': 'additional', 'affiliation': []}],
'member': '33699',
'published-online': {'date-parts': [[2024, 6, 9]]},
'reference': [ { 'key': '4575',
'doi-asserted-by': 'crossref',
'unstructured': 'Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. '
'Pathophysiology, transmission, diagnosis, and treatment of Coronavirus '
'disease 2019 (COVID-19): A review. JAMA 2020; 324: 782.',
'DOI': '10.1001/jama.2020.12839'},
{ 'key': '4576',
'doi-asserted-by': 'crossref',
'unstructured': 'Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 '
'severity and fatality: a structured literature review. Infection 2021; '
'49: 15–28.',
'DOI': '10.1007/s15010-020-01509-1'},
{ 'key': '4577',
'doi-asserted-by': 'crossref',
'unstructured': 'D’Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R, et '
'al. 25-hydroxyvitamin D concentrations are lower in patients with '
'positive PCR for SARS-CoV-2. Nutrients 2020; 12: 1359.',
'DOI': '10.3390/nu12051359'},
{ 'key': '4578',
'doi-asserted-by': 'crossref',
'unstructured': 'Wang Z, Joshi A, Leopold K, Jackson S, Christensen S, Nayfeh T, et al. '
'Association of vitamin D deficiency with COVID‐19 infection severity: '
'Systematic review and meta‐ analysis. Clin Endocrinol (Oxf) 2022; 96: '
'281-7.',
'DOI': '10.1111/cen.14540'},
{ 'key': '4579',
'doi-asserted-by': 'crossref',
'unstructured': 'Karatekin G, Kaya A, Salihoğlu Ö, Balci H, Nuhoğlu A. Association of '
'subclinical vitamin D deficiency in newborns with acute lower '
'respiratory infection and their mothers. Eur J Clin Nutr 2009; 63: '
'473–7.',
'DOI': '10.1038/sj.ejcn.1602960'},
{ 'key': '4580',
'doi-asserted-by': 'crossref',
'unstructured': 'Dimitrov V, White JH. Species-specific regulation of innate immunity by '
'vitamin D signaling. J Steroid Biochem Mol Biol 2016; 164: 246–53.',
'DOI': '10.1016/j.jsbmb.2015.09.016'},
{ 'key': '4581',
'doi-asserted-by': 'crossref',
'unstructured': 'Sassi F, Tamone C, D’Amelio P. Vitamin D: Nutrient, hormone, and '
'immunomodulator. Nutrients 2018; 10: 1656.',
'DOI': '10.3390/nu10111656'},
{ 'key': '4582',
'doi-asserted-by': 'crossref',
'unstructured': 'Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz '
'G, et al. Vitamin D supplementation to prevent acute respiratory '
'infections: individual participant data meta-analysis. Health Technol '
'Assess 2019; 23: 1–44.',
'DOI': '10.3310/hta23020'},
{ 'key': '4583',
'unstructured': 'SACN. Update of rapid review: Vitamin D and acute respiratory tract '
'infections. Accessed November11 2022. '
'https://assetspublishingservicegovuk/government/uploads/system/uploads/attachment_data/file/945179/SACN_December2020_VitaminD_AcuteRespiratoryTractInfectionspdf.'},
{ 'key': '4584',
'doi-asserted-by': 'crossref',
'unstructured': 'Mercola J, Grant WB, Wagner CL. Evidence regarding vitamin D and risk of '
'COVID-19 and its severity. Nutrients 2020; 12: 3361.',
'DOI': '10.3390/nu12113361'},
{ 'key': '4585',
'doi-asserted-by': 'crossref',
'unstructured': 'Teshome A, Adane A, Girma B, Mekonnen ZA. The impact of vitamin D level '
'on COVID-19 infection: Systematic review and meta-analysis. Front Public '
'Health 2021; 9: 624559.',
'DOI': '10.3389/fpubh.2021.624559'},
{ 'key': '4586',
'doi-asserted-by': 'crossref',
'unstructured': 'Shah K, Varna VP, Sharma U, Mavalankar D. Does vitamin D supplementation '
'reduce COVID-19 severity?: a systematic review. QJM 2022; 115: 665–72.',
'DOI': '10.1093/qjmed/hcac040'},
{ 'key': '4587',
'doi-asserted-by': 'crossref',
'unstructured': 'Ye K, Tang F, Liao X, Shaw BA, Deng M, Huang G, et al. Does serum '
'vitamin D level affect COVID-19 infection and its severity? -A '
'case-control study. J Am Coll Nutr 2021; 40: 724–31.',
'DOI': '10.1080/07315724.2020.1826005'},
{ 'key': '4588',
'doi-asserted-by': 'crossref',
'unstructured': 'Siwamogsatham O, Ongphiphadhanakul B, Tangpricha V. Vitamin D deficiency '
'in Thailand. J Clin Transl Endocrinol 2015; 2: 48–9.',
'DOI': '10.1016/j.jcte.2014.10.004'},
{ 'key': '4589',
'unstructured': 'COVID-19 Treatment Guidelines. National Institutes of Health (US). 2019; '
'In: Coronavirus Disease 2019 (COVID-19)'},
{ 'key': '4590',
'doi-asserted-by': 'crossref',
'unstructured': 'Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney '
'RP, et al. Evaluation, treatment, and prevention of vitamin D '
'deficiency: An endocrine society clinical practice guideline. J Clin '
'Endocrinol Metab 2011; 96: 1911–30.',
'DOI': '10.1210/jc.2011-0385'},
{ 'key': '4591',
'doi-asserted-by': 'crossref',
'unstructured': 'Hossein-nezhad A, Holick MF. Vitamin D for health: A global perspective. '
'Mayo Clin Proc 2013; 88: 720–55.',
'DOI': '10.1016/j.mayocp.2013.05.011'},
{ 'key': '4592',
'doi-asserted-by': 'crossref',
'unstructured': 'Campi I, Gennari L, Merlotti D, Mingiano C, Frosali A, Giovanelli L, et '
'al. Vitamin D and COVID-19 severity and related mortality: a prospective '
'study in Italy. BMC Infect Dis 2021; 21: 566.',
'DOI': '10.1186/s12879-021-06281-7'},
{ 'key': '4593',
'doi-asserted-by': 'crossref',
'unstructured': 'Palacios C, Gonzalez L. Is vitamin D deficiency a major global public '
'health problem? J Steroid Biochem Mol Biol 2014;n144: 138–45.',
'DOI': '10.1016/j.jsbmb.2013.11.003'},
{ 'key': '4594',
'doi-asserted-by': 'crossref',
'unstructured': 'Chailurkit L-O, Aekplakorn W, Ongphiphadhanakul B. Regional variation '
'and determinants of vitamin D status in sunshine-abundant Thailand. BMC '
'Public Health 2011; 11: 853.',
'DOI': '10.1186/1471-2458-11-853'},
{ 'key': '4595',
'doi-asserted-by': 'crossref',
'unstructured': 'Adami G, Rossini M, Bogliolo L, Cantatore FP, Varenna M, Malavolta N, et '
'al. An exploratory study on the role of vitamin D supplementation in '
'improving pain and disease activity in rheumatoid arthritis. Mod '
'Rheumatol 2019; 29: 1059–62.',
'DOI': '10.1080/14397595.2018.1532622'},
{ 'key': '4596',
'doi-asserted-by': 'crossref',
'unstructured': 'Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA. Perspective: '
'Vitamin D deficiency and COVID‐19 severity – plausibly linked by '
'latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis. J Intern '
'Med 2021; 289: 97–115.',
'DOI': '10.1111/joim.13149'},
{ 'key': '4597',
'doi-asserted-by': 'crossref',
'unstructured': 'Annweiler C, Hanotte B, Grandin de l’Eprevier C, Sabatier J-M, Lafaie L, '
'Célarier T. Vitamin D and survival in COVID-19 patients: A '
'quasi-experimental study. J Steroid Biochem Mol Biol 2020; 204: 105771.',
'DOI': '10.1016/j.jsbmb.2020.105771'},
{ 'key': '4598',
'doi-asserted-by': 'crossref',
'unstructured': 'Nimitphong H, Holick MF. Vitamin D status and sun exposure in southeast '
'Asia. Dermatoendocrinol 2013; 5: 34–7.',
'DOI': '10.4161/derm.24054'},
{ 'key': '4599',
'doi-asserted-by': 'crossref',
'unstructured': 'Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. '
'Respiratory epithelial cells convert inactive vitamin D to its active '
'form: Potential effects on host defense. J Immunol 2008; 181: 7090–9.',
'DOI': '10.4049/jimmunol.181.10.7090'},
{ 'key': '4600',
'doi-asserted-by': 'crossref',
'unstructured': 'Jiang J-S, Chou H-C, Chen C-M. Cathelicidin attenuates hyperoxia-induced '
'lung injury by inhibiting oxidative stress in newborn rats. Free Radic '
'Biol Med 2020; 150: 23–9.',
'DOI': '10.1016/j.freeradbiomed.2020.02.005'},
{ 'key': '4601',
'doi-asserted-by': 'crossref',
'unstructured': 'Aranow C. Journal of investigative medicine : the official publication '
'of the American Federation for Clinical Research 2011; 59 : 881–6.',
'DOI': '10.2310/JIM.0b013e31821b8755'},
{ 'key': '4602',
'doi-asserted-by': 'crossref',
'unstructured': 'Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Is there an '
'association between COVID-19 mortality and the renin-angiotensin system? '
'A call for epidemiologic investigations. Clin Infect Dis 2020; 71: '
'870–4.',
'DOI': '10.1093/cid/ciaa329'},
{ 'key': '4603',
'doi-asserted-by': 'crossref',
'unstructured': 'Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, et '
'al. Effect of a single high dose of vitamin D3 on hospital length of '
'stay in patients with moderate to severe COVID-19: A randomized clinical '
'trial. JAMA 2021; 325: 1053.',
'DOI': '10.1001/jama.2020.26848'}],
'container-title': 'Journal of Southeast Asian Medical Research',
'original-title': [],
'link': [ { 'URL': 'https://jseamed.org/index.php/jseamed/article/download/202/133',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://jseamed.org/index.php/jseamed/article/download/202/133',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2024, 6, 9]],
'date-time': '2024-06-09T02:57:26Z',
'timestamp': 1717901846000},
'score': 1,
'resource': {'primary': {'URL': 'https://jseamed.org/index.php/jseamed/article/view/202'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2024, 6, 9]]},
'references-count': 29,
'URL': 'http://dx.doi.org/10.55374/jseamed.v8.202',
'relation': {},
'ISSN': ['2697-5424', '2586-8241'],
'subject': [],
'container-title-short': 'J Southeast Asian Med Res',
'published': {'date-parts': [[2024, 6, 9]]}}